6th patient conversion in InVivo's INSPIRE Study— 5 observations

Spinal Tech

Cambridge, Mass.-based InVivo Therapeutics reported the sixth patient conversion in its INSPIRE study testing the Neuro-Spinal Scaffold.

Here are five observations:

 

1. The patient has improved, going from a complete AIS A spinal cord injury to an incomplete AIS B spinal cord injury, between discharge and the one-month follow-up.

 

2. The study has now seen a 54.5 percent conversion rate among the 11 enrolled patients.

 

3. The patient enrolled in the INSPIRE study at Charlotte, N.C.-based Carolina Neurosurgery and Spine Associates/Carolinas Rehabilitation in December 2016.

 

4. Domagoj Coric, MD, and Samuel Chewning, MD, implanted the Neuro-Spinal Scaffold in the patient.

 

5. The INSPIRE study tests the Neuro-Spinal Scaffold's efficacy and safety for complete thoracic AIS A spinal cord injury.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers